SCHEMBL1587424

SCHEMBL1587424

NNC(=O)c1ccc(C(=O)NCCc2ccncc2)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 2/20 0.55
▸ HDAC2 Q92769 1/20 0.55
▸ HDAC8 Q9BY41 1/20 0.55
▸ RAB9A P51151 5/20 0.54
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ NPC1 O15118 4/20 0.54
▸ HDAC3 O15379 1/20 0.52
▸ HDAC4 P56524 1/20 0.52
▸ HDAC1 Q13547 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.51
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ HIF1A Q16665 3/20 0.46
▸ CHRM4 P08173 1/20 0.46
▸ AKT3 Q9Y243 1/20 0.46
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA5A P35218 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA5B Q9Y2D0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1588059 0.92 NPC1 (0.54) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL1587179 0.85 HSD17B10 (0.53) HDAC6SMN1; SMN2HDAC3HDAC4HDAC1
SCHEMBL1587804 0.85 RAB9A (0.53) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL12789016 0.84 RAB9A (0.71) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL4931299 0.83 HDAC6 (0.64) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL12723016 0.82 RAB9A (0.55) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL11984349 0.81 RAB9A (0.52) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL14625417 0.79 NPC1 (0.56) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL4962654 0.78 HRH1 (0.46) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2
SCHEMBL4964688 0.78 NPC1 (0.78) HDAC6HDAC2HDAC8RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968542-B2 Thiophene compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-28 — — US disclosed
US-7968542-B2 Thiophene compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-28 — — US disclosed
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-04-21 — — US disclosed
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-04-21 — — US disclosed
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2009-05-07 — — US disclosed
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2009-05-07 — — US disclosed
WO-2007010954-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-01-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO HDAC6 3330/4885HDAC2 3236/4885HDAC8 2197/4885
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO HDAC6 3330/4885HDAC2 3236/4885HDAC8 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback